Legence Q3 Results: Sales Guidance $1.225B-$1.275B vs $1.08B Est

0 min read Updated on 13 Aug 2026, 06:29 PM

Reviewed by

Jubin VScanX News Team

AI Summary

Legence forecasts Q3 revenue between $1.225 billion and $1.275 billion, beating the $1.080 billion analyst estimate. The guidance implies a significant upside to market expectations, highlighting strong anticipated performance for the quarter.

*this image is generated using AI for illustrative purposes only.

Legence (NASDAQ: LGN) has projected third-quarter sales to fall within the range of $1.225 billion to $1.275 billion, marking a substantial deviation from market expectations.

The company's guidance exceeds the consensus analyst estimate of $1.080 billion. This positive variance suggests that Legence anticipates stronger-than-expected demand or pricing power during the quarter, outperforming the baseline assumptions held by financial analysts.

What the Numbers Show

The gap between the lower bound of the guidance ($1.225 billion) and the analyst estimate ($1.080 billion) is approximately $145 million. Even at the conservative end of its forecast, Legence expects to deliver revenue nearly 13% higher than the street consensus. This indicates a clear divergence between the company's internal visibility and external market sentiment, potentially reflecting recent order wins or supply chain improvements not yet fully priced in by analysts.

Metric:	Value
Q3 Sales Guidance (Low):	$1.225 billion
Q3 Sales Guidance (High):	$1.275 billion
Analyst Estimate:	$1.080 billion

No other financial metrics, such as net profit, EBITDA, or margin figures, were disclosed in the source data.

Will Legence's Q3 revenue beat lead to a significant upward revision in full-year earnings estimates from Wall Street analysts?

How might this substantial guidance increase impact Legence's stock valuation multiples compared to its packaging industry peers?

Are there specific new client contracts or supply chain efficiencies driving the 13% upside that could sustain momentum into Q4?

Read Next Article

RBC Capital maintains Outperform on Legence, lowers price target to $101

0 min read Updated on 22 Jul 2026, 11:00 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

AI Summary

RBC Capital analyst Sabahat Khan maintained an Outperform rating on Legence (NASDAQ: LGN) but lowered the price target to $101 from $106.

*this image is generated using AI for illustrative purposes only.

RBC Capital analyst Sabahat Khan has maintained an Outperform rating on Legence while lowering the price target to $101 from the previous $106. The revised target indicates a recalibrated valuation for the company listed on NASDAQ under the ticker LGN.

The rating retention suggests continued confidence in the company's fundamental performance despite the reduction in the price objective. Legence operates within the financial markets, and the adjusted target provides investors with an updated reference point for the stock's potential trajectory.